Xeris Biopharma Holdings
XERS
XERS
93 hedge funds and large institutions have $115M invested in Xeris Biopharma Holdings in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 20 increasing their positions, 35 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
29% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 35
43% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 35
Holders
93
Holding in Top 10
–
Calls
$8.9M
Puts
$2.39M
Top Buyers
| 1 | +$1.15M | |
| 2 | +$994K | |
| 3 | +$989K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$954K |
| 5 |
Renaissance Technologies
New York
|
+$728K |
Top Sellers
| 1 | -$8.47M | |
| 2 | -$2.95M | |
| 3 | -$2.32M | |
| 4 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$1.58M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.49M |